Back to Market Feed

DELSTRIGO 100-300-300 MG TAB

doravirine, lamivudine, and tenofovir disoproxil fumarate
$92.9143per EA

Strength

100; 300; 300 mg/1; mg/1; mg/1

NDC

00006500701

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/6/2026

Approval Type

New Drug (NDA)

FDA Application

NDA210807

On Market Since

7/20/2018

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleosides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.5%

1Y

+2.7%

3Y

N/A

5Y

N/A

All

+12.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

EPIVIR 10 MG/ML ORAL SOLN
Brand
49702020548•ViiV Healthcare Company
$0.4452
per ML
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
EPIVIR 150 MG TABLET
Brand
49702020318•ViiV Healthcare Company
$6.6144
per EA
IMURAN 50 MG TABLET
Brand
54766059010•Sebela Pharmaceuticals Inc.
$8.8907
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
EPIVIR 300 MG TABLET
Brand
49702020413•ViiV Healthcare Company
$13.2940
per EA
COMBIVIR TABLET
Brand
49702020218•ViiV Healthcare Company
$14.3948
per EA
EMTRIVA 200 MG CAPSULE
Brand
61958060101•Gilead Sciences, Inc.
$17.4370
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.2861
per EA
VIREAD 300 MG TABLET
Brand
61958040101•Gilead Sciences, Inc.
$40.7318
per EA